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The antioxidant potential of the
Mediterranean diet in patients at high
cardiovascular risk: an in-depth review of
the PREDIMED
Hayley E Billingsley1 and Salvatore Carbone 1,2
Abstract
Cardiovascular disease (CVD) is the leading global cause of death. Diet is known to be important in the prevention of
CVD. The PREDIMED trial tested a relatively low-fat diet versus a high-fat Mediterranean diet (MedDiet) for the primary
prevention of CVD. The resulting reduction of the CV composite outcome resulted in a paradigm shift in CV nutrition.
Though many dietary factors likely contributed to this effect, this review focuses on the influence of the MedDiet on
endogenous antioxidant systems and the effect of dietary polyphenols. Subgroup analysis of the PREDIMED trial
revealed increased endogenous antioxidant and decreased pro-oxidant activity in the MedDiet groups. Moreover,
higher polyphenol intake was associated with lower incidence of the primary outcome, overall mortality, blood
pressure, inflammatory biomarkers, onset of new-onset type 2 diabetes mellitus (T2DM), and obesity. This suggests
that polyphenols likely contributed to the lower incidence of the primary event in the MedDiet groups. In this article,
we summarize the potential benefits of polyphenols found in the MedDiet, specifically the PREDIMED cohort. We also
discuss the need for further research to confirm and expand the findings of the PREDIMED in a non-Mediterranean
population and to determine the exact mechanisms of action of polyphenols.
Introduction
Cardiovascular disease (CVD) is the leading global cause
of death, claiming an estimated 17.3 million lives in 20131.
Oxidative stress and systemic inflammation are impor-
tant contributing factors in the development and pro-
gression of CVD2–4. Diet, which contributed to an
estimated one in two cardiometabolic deaths in the Uni-
ted States in 20105, may play an important role in mod-
ifying oxidative stress and inflammation. However,
evidence for the effects of diet on CV outcomes mainly
relies heavily on observational data. Therefore, the results
of the multicenter “Primary Prevention of Cardiovascular
Disease with a Mediterranean Diet” trial (PREDIMED)
resulted in a paradigm shift in nutrition recommendations
for preventing CVD. PREDIMED tested the hypothesis
that the Mediterranean diet (MedDiet) is more effective in
preventing CVD than a relatively low-fat diet in a rigorous
randomized-control fashion6.
PREDIMED enrolled 7447 participants free of CVD at
baseline, but at a high risk for CVD, who were rando-
mized 1:1:1 to three groups: two caloric-unrestricted
MedDiet groups receiving either ~1 liter per week of
extra-virgin olive oil (EVOO) or 30 g of mixed nuts
per day, and one group counseled to follow a low-fat diet6.
The low-fat diet counseling included encouraging lean
fish and poultry, low-fat dairy products, fruits, vegetables,
and starches including bread, pasta, potatoes, and rice
while minimizing use of oils, nuts, fatty fish and meats,
commercial baked goods, and fried foods. Objective
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compliance to the respective Mediterranean diet inter-
vention was tested with plasma alpha-linoleic acid (nuts
group) and urine hydroxytyrosol (EVOO group) at base-
line, 1, 3, and 5 years, respectively. The trial was termi-
nated early, after interim analysis revealed a dramatic
divergence for the primary end point between the groups
at median follow-up of 4.8 years. Analysis revealed an
impressive relative risk reduction of 30% in the primary
composite outcome (acute myocardial infarction, stroke,
or death from CV causes) for the two MedDiet groups
compared to the low-fat control diet group (Fig. 1)6. The
reduction of CVD was particularly evident for stroke.
It is important to note that the benefit of the Medi-
terranean diet in the PREDIMED trial was likely due to
numerous factors, notably a high-unsaturated fat con-
tent7, 8, as well as the effects of other macro and micro-
nutrients and polyphenols. It is impossible to distinguish
which dietary factor led to the most benefit, most likely
the summation of beneficial factors in the Mediterranean
diet9, 10.
This review, however, will discuss the overall MedDiet
tested in the PREDIMED and more specifically will focus
on the ability of dietary polyphenols and vitamin anti-
oxidants on altering oxidative stress, and most impor-
tantly, clinical outcomes.
PREDIMED population and baseline oxidative stress level
Conducted in Spain, PREDIMED was a multicenter
randomized-controlled trial that enrolled men and
women 55–80 years of age with a high risk for CVD6. To
be enrolled, participants either had type II diabetes (50%)
at baseline or three or more risk factors as follows: current
smoker (14%), dyslipidemia (>70%), overweight/obese
(>90%), and family history of CVD (22%). When a sample
of the PREDIMED cohort (n= 527) was compared to
healthy controls (n= 25) before randomization, it was
found that oxidative stress markers including damaged
DNA base 8-oxo-dG, malondialdehyde (MDA), oxidized
glutathione (GSSG), and the GSSG/glutathione (GSH)
ratio were increased, revealing a more negative oxidative
stress profile in the individuals with high CVD risk11.
Increased GSSG is usually associated with early athero-
sclerosis in healthy adults12. However, in addition to
oxidative stress levels, is important to analyze the endo-
genous antioxidant activity13. Endogenous antioxidant
activity, measured as catalase (CAT) and glutathione
peroxidase (GPx) activity, were higher in healthy sub-
jects11, suggesting that in addition to lower oxidative
stress levels, there was an increased antioxidant defense.
Interestingly, a different sample of PREDIMED (n= 1069)
found that increasing GPx activity was linearly associated
with increasing blood glucose and oxidized Low-density
Lipoprotein (LDL)14. The authors suggest this may be an
indicator of the oxidative stress balance, likely in this case,
an antioxidant response to increased presence of oxidative
stress as compensatory mechanism14. Such findings sug-
gest that a comprehensive assessment of oxidative stress
level in association with endogenous antioxidant capacity
should be recommended for a clearer picture of the
overall oxidative stress/antioxidant balance.
Returning to the previous sample of 527 subjects, the
presence of hypertension was the most important risk
factor in determining differences in oxidative stress
parameters11. Most of the oxidative stress measures listed
above (i.e., higher GSSG, GSSG/GSH ratio, trend toward
higher MDA) were increased in hypertensive subjects
compared to those without hypertension. It should be
noted that the activity of endogenous antioxidants GPx
and superoxide dismutase (SOD) were also significantly
increased in hypertensive subjects but were still at sig-
nificantly lower levels than the healthy controls11.
This baseline data on the PREDIMED cohort demon-
strates an elevated oxidative stress in individuals at high
CVD risk, creating ample opportunity to explore the
effect of the MedDiet.
Effects of MedDiet on endogenous antioxidant systems
The MedDiet’s beneficial effects are usually attributed
to the action of nutrients within foods consumed but the
overall dietary pattern may also enhance the body’s
endogenous defenses through mechanisms not fully
understood15. A small sample (n= 75) of the PREDIMED
cohort was analyzed for the effect of dietary intervention
influence on plasmatic antioxidant and pro-oxidant
activity prior to and post intervention16. In this study,
prior to dietary intervention, EVOO- or nuts-
supplemented groups presented lower plasma activity of
antioxidant extracellullar SOD (EC-SOD) and catalase
(CAT) activity compared to healthy controls. After
intervention (median 4.8 years in entire cohort), activity of
Fig. 1 Kaplan–Meier curve for incidence of primary outcome
(composite of acute myocardial infarction, stroke, or death from
cardiovascular causes) in the PREDIMED trial after a median
follow-up of 4.8 years for participants. With permission from
Estruch et al.6
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EC-SOD and CAT was enhanced in both MedDiet
groups16. Additionally, pro-oxidant xanthine oxidase
(XOX) had decreased activity in both MedDiet groups.
When further analyzed for degree of adherence as mea-
sured by questionnaire, plasma antioxidant activity of EC-
SOD and CAT increased with greater adherence to the
MedDiet, while pro-oxidant XOX activity decreased with
greater MedDiet adherence16. However, no differences
were seen in plasma markers of oxidative damage and no
differences were seen in functionality of serum myelo-
peroxidase or whole blood and blood cell EC-SOD and
CAT16. When total antioxidant capacity (TAC) of serum
was measured in another subset of PREDIMED partici-
pants (n= 187), the subjects randomized to EVOO-
supplemented MedDiet and nuts-supplemented Med-
Diet had greater TAC than the subjects randomized to the
relatively low-fat control diet17. Within EVOO- and nuts-
supplemented MedDiet groups, EVOO-supplemented
MedDiet induced an even further increase in TAC com-
pared to the nuts-supplemented MedDiet17. In an addi-
tional analysis of this substudy, the TAC was also
associated with weight loss in the EVOO intervention
group, suggesting that greater TAC may be involved in
body weight regulation. However, a major limitation of this
additional analysis was that total caloric intake was not
included in the multivariate17, therefore we cannot deter-
mine whether such association was independent of total
energy intake. From this subanalysis, however, it is not
possible to determine whether TAC directly affected body
weight, or viceversa, suggesting the need for further study.
Importance of dietary antioxidants and polyphenols
Dietary vitamin antioxidants and polyphenols have been
explored extensively as an exogenous mechanism of
defense against oxidative stress, systemic inflammation,
and finally, the development of non-communicable dis-
ease18–20. Increased dietary antioxidant content (i.e.,
vitamins and polyphenols) has been associated with
reduced incident of heart failure21, stroke22, coronary
artery disease23, and cancer24. It should be emphasized
that this does not include antioxidant supplementation,
which does not decrease mortality25.
The MedDiet is rich in both vitamins and polyphenols,
which are mainly, but not exclusively contained in fruits,
vegetables, whole grains, nuts, EVOO, and red wine26.
The traditional vitamin antioxidants are usually beta-
carotene (vitamin A precursor), vitamins C, vitamin E,
and often the mineral selenium27. In contrast, poly-
phenols encompass a wide range of secondary plant
metabolites characterized by a large number of phenol
groups28. Polyphenols are produced in response to a
threat (e.g., radiation, pathogens)29 and it has been
hypothesized that their protective ability may also have
importance in the human body30. Multiple hydroxyl
groups make polyphenols strong antioxidants but they
also carry anti-inflammatory properties31. In fact, they can
interfere with a number of proinflammatory pathways
such as the Nod-like receptor pyrin domain-containing
protein (NLRP)3 inflammasome, nuclear factor kappa B
(NFkB), and mitogen-activated protein kinase (MAPK)28,
31. Particularly, in vitro studies suggested that the inhi-
bition of these transcription factors or macromolecular
complexes induced by polyphenols may reduce the
synthesis and release of proinflammatory cytokines such
as interleukin(IL)-1β, IL-6, IL-8, and tumor necrosis fac-
tor (TNF-a), which have in turn, been associated with
adverse CV events28, 32. However, their powerful in vitro
anti-inflammatory effects may not necessarily translate to
the same beneficial effects in vivo, as polyphenols bioa-
vailability varies quite considerably33.
Effect of dietary antioxidants
An analysis of the PREDIMED focused on total dietary
antioxidant capacity—including all compounds with
antioxidant potential (vitamin antioxidants and poly-
phenols)34. The quantity of both polyphenols and vitamin
antioxidants was determined by dietary intake informa-
tion collected by validated 137-question food frequency
questionnaire (FFQ) for all participants at baseline and
then once annually during follow-up6. Total dietary
antioxidant capacity was then determined by converting
the FFQ to the 24-h dietary recalls and then using a
database with antioxidant potential of each food deter-
mined by a specific assay34. In this analysis of the entire
PREDIMED cohort, those who where in the highest
quintile of total antioxidants consumption presented a
non-significant 15 and 21% relative risk reduction in
overall and CV mortality for PREDIMED, respectively.
There was no correlation found between antioxidant
consumption and cancer-related mortality34.
Effect of dietary polyphenols
While the role of vitamin antioxidants in the PREDIMED
was, to date, only discussed in one study34, the effects of
polyphenols were far more extensively studied. At baseline,
for the 7200 PREDIMED subjects who completed a FFQ,
the main source of polyphenols was fruit, followed by non-
alcoholic beverages (i.e., coffee, orange juice, tea), and
vegetables35. As for individual sources, coffee (18%) was
the main food source of total dietary polyphenols, followed
by oranges (16%), apples (12%), olives and olive oil (11%),
and lastly, red wine (6%). However, this substudy did not
assess potential changes of polyphenols sources over time,
which may have occurred when participants were rando-
mized into the dietary intervention groups6. Of note,
PREDIMED was conducted in a Mediterranean country
(Spain), which likely influenced baseline dietary pattern
and therefore sources of polyphenols.
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In another analysis of PREDIMED participants (n=
7172), which only included those with a baseline FFQ and
plausible energy intake, a multivariate analysis adjusting
for age, BMI, smoking status, physicial activity, and energy
intake, as well as selected nutrient intake, medications and
CV risks, found that individuals in the highest quintile vs.
the lowest quintile of polyphenols intake measured by
FFQ had a significant 46% relative risk reduction in the
primary composite CV outcome36. However, when the
three randomized groups were analyzed individually, this
association was only apparent in the control group
assigned to the relatively low-fat diet36. The authors
postulated that this was possibly influenced by the rela-
tively small event rate in both MedDiet intervention
groups36. Interestingly, the subjects in the highest quintile
of polyphenols presented a relative mortality risk reduc-
tion of 37% compared to those in the lowest quintiles of
polyphenols intake37. However, the authors noted this was
not a strong linear association and the association les-
sened after the lowest quintile of polyphenol intake was
removed from the analysis. Figure 2 demonstrates the
separation in crude mortality rates of the partcipants
divided into tertiles by low, medium, and high con-
sumption of polyphenols37. When looking at the indivi-
dual polyphenols, the polyphenols associated with the
greatest all-cause mortality reduction were stilbenes and
lignans37. Such results were confirmed also in relation to
the primary outcome, indeed the top quintile of con-
sumption of the polyphenol lignan was associated with a
49% relative risk reduction of the composite CV primary
outcome of the study36. Although the mechanisms
underlying such improvements are still largely unknown,
lignans exert a number of potential beneficial effects such
as anti-inflammatory, antioxidant, and anti-tumor
properties38. The greatest source of lignans in the PRE-
DIMED cohort was EVOO34 and another PREDIMED
analysis demonstrated a potential ability of the poly-
phenols present in EVOO to downregulate the expression
of pro-atherosclerosis genes and related inflammatory and
lipid oxidative markers39.
Of note, polyphenol content can differ dramatically
between different olive oil products. EVOO has the
highest content of polyphenols with four main groups of
phenol compounds: simple phenols (hydroxytyrosol),
flavonoids, secoiridoids, and lignans40. Hydroxytyrosol is
particularly important also due to its urinary excretion,
which allows to measure compliance to EVOO con-
sumption41. Moreover, hydroxytyrosol has the highest
antioxidant potential of the phenol compounds contained
in olive oil, at least in vitro39.
The influence of polyphenols on inflammatory markers
and CV risk factors was also investigated. Total poly-
phenol excretion (TPE) in the urine is a validated method
of dietary polyphenol quantification42. One substudy of
randomly selected PREDIMED subjects (n= 1139)
demonstrated that individuals in the two MedDiet cohorts
(EVOO and nuts) significantly increased their TPE after 1
year of intervention and decreased systemic inflammatory
biomarkers from baseline including circulating vascular
cell adhesion molecule 1, (VCAM-1), soluble inter cellular
adhesion molecule 1 (ICAM-1), IL-6, TNF-α, and
monocyte chemotactic protein 1 (MCP-1)43. Conversely,
these molecules with potential detrimental effects
increased in the control group, although the difference did
not reach statistical significance43. When all patients were
separated into tertiles based on changes in TPE, a dif-
ference was demonstrated between the highest and lowest
tertiles of increase in TPE and the change in levels of the
inflammatory biomarkers listed above (i.e., VCAM-1,
ICAM-1, IL-6, TNF- α, MCP-1)43.
The substudies and analyses contained in this section
present the possibility that polyphenol intake is linked to
systemic inflammation and overall mortality. However, it
must be taken into consideration that the polyphenol
analyses36, 37 were extrapolated from the main study6,
which was not initially designed to look at the effects of
polyphenols. Moreover, although the investigators per-
formed several statistical adjustments to the multivariate
analysis to minimize the potential of confounders, it is
possible that other confounding factors existed and for
which the statistical analysis could not fully account for.
Additionally, such studies cannot prove causation, there-
fore future randomized-controlled trial modulating poly-
phenols intake are warranted to confirm these effects.
TPE and blood pressure
A cross-section substudy of PREDIMED performed at
baseline (n= 589), demonstrated that patients in the
Fig. 2 Nelson Aalen survival function of the PREDIMED cohort
divided into tertiles of polyphenol consumption. With permission
from Tressera-Rimbau et al.37
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highest quintile of urinary TPE had 36% lower risk of
having hypertension compared to the lowest TPE quin-
tile, even after multivariate analysis, which included
gender, age, weight, smoking, physical activity, educa-
tion, medication use, sodium/potassium intake, and
glomular filtration rate44. The interaction between blood
pressure, nitric oxide (NO), and polyphenols measured
by TPE was also assessed in another sample (n= 200)
after 1 year of dietary interventions45. In this particular
substudy, intervention groups displayed a significant
lowering of systolic blood pressure −5.79 mmHg and
−7.26 mmHg with MedDiet with EVOO and nuts,
respectively, after 1 year of follow-up45. In the entire
PREDIMED cohort, this effect was less preminent, and
no clinically significant diastolic blood pressure-lowering
was observed in the MedDiet groups versus the control
after 4 years of follow-up46. Higher quintiles of TPE were
also associated with increased NO levels and the authors
attributed the blood pressure-lowering effects of the
MedDiet to the action of the polyphenols on increasing
NO, therefore causing vasodilation, as previously shown
in vitro45.
The studies presented above suggest that polyphenol
intake may have a blood pressure-lowering effect44, 45.
However, it should be noted that both studies44, 45 are
very small samples of the PREDIMED cohort46.
TPE, incident type 2 diabetes mellitus, and obesity
Incidence of type 2 diabetes mellitus (T2DM) was a pre-
specified outcome of the PREDIMED trial47. A subgroup
analysis of 3541 participants showed a 52% relative risk
reduction of T2DM after a median follow-up of 4.0 years
in the combined MedDiet groups, even in absence of body
weight and physical activity changes over the duration of
the study48. A significant reduction of new-onset T2DM
was also found in those with the highest (versus the
lowest) baseline intake of polyphenols after 5.5 years of
follow-up in 3430 patients free from T2DM at baseline49.
Additionally, in a cross sectional substudy (n= 573), a
significant inverse correlation was found between new-
onset obesity and individuals in the highest versus lowest
quintile of polyphenol intake measured by urinary TPE50.
Protection against weight gain is one plausible mechanism
by which higher dietary polyphenols may help prevent
new-onset T2DM, but a recent review also suggested
several mechanisms for the association between poly-
phenols and reduction in T2DM risk including improved
insulin sensitivity, reduction of oxidative stress, and sys-
temic low-grade inflammation51.
It is important to note in the two studies mentioned
above assessed polyphenols differently—one by dietary
intake49 and the other by TPE50. Additionally, all three
studies mentioned contain 50% or less of the total PRE-
DIMED cohort48–50.
Discussion
Individuals with high CV risk who consume high
amounts of polyphenols may present a lower risk of
developing CV events and mortality by potential mod-
ulation of risk factors such as systemic inflammation43,
obesity50, blood pressure44, 45, and T2DM49.
Only one substudy of the PREDIMED analyzed the
effects of vitamin antioxidants on major CV events34, so
their individual contribution to the different end points of
the study cannot be determined.
It is acknowledged that the evidence regarding poly-
phenols presented in the above paper was not a pre-
specified outcome of the orginal PREDIMED trial. The
studies presented are substudies and analyses of various
sizes and methodologies, and the results should be
interpreted with caution and used for hypothsis-
generating purposes. Morevoer, while multivariate
adjustment is performed in most of statistical analyses, it
is impossible to fully adjust for every possible confound-
ing factor. Additionally, causation cannot be proven by
such studies and appropriately powered randomized-
controlled dietary trials of polyphenols modulation are
required to expand these observations.
Polyphenols often are consumed in the form of fruits,
vegetables, and other plant-derived food products52 that
have nutrients such as dietary fiber with established
health benefits53, but also EVOO54 and nuts55. Within the
limitation of the studies analyzed herein (i.e., limited
sample size, subgroup analysis), the evidence would sug-
gest that polyphenols are a powerful piece of the puzzle
that makes the MedDiet a powerful prevention tool in the
hands of the provider (Fig. 3). In addition to polyphenols,
however, the MedDiet is also very rich in unsaturated
fatty acids (UFA). It has been increasingly recognized that
a diet high in UFA is extremely important for CV health56.
However, food rich in UFA are often also rich in poly-
phenols (i.e., EVOO), making it very difficult to differ-
entiate the beneficial individual effects of one component
or the other. The difficultly of disentangling the beneficial
effects of the dietary intervention versus the more com-
prehensive Mediterranean dietary pattern has been fully
acknowledged by the PREDIMED investigators57. It is
fully possible that a combination of the polyphenols and
UFA is required for a more powerful beneficial effect
(Fig. 3).
Taken together, these data presented in this review can
also serve as evidence toward what the ideal MedDiet for
the prevention of chronic disease may look like as the
phrase “Mediterranean diet” describes a pattern of eating
that may vary regionally among the Mediterranean
countries58. Additionally, this could inform the updates of
dietary guidelines to help consumers and health profes-
sionals better understand how to instruct and comply
with the MedDiet as dietary patterns are being
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increasingly emphasized over individual foods and nutri-
ents in the United States Dietary guidelines59.
A notable limitation of the PREDIMED is the minimal
guidance the low-fat diet participants received in the first
3 years of the trial. Though both groups received baseline
dietary counseling, the MedDiet groups received follow-
up in the form of personalized, quarterly counseling but
the low-fat diet participants only received an annual
informational pamphlet. This was admended due to the
concern for bias and low-fat diet participants began
receiving personalized counseling as frequently as the
MedDiet groups in 2006. Importantly, after analysis, no
difference in benefit was demonstrated with respect to
enrollment period between the MedDiet and the low-fat
groups suggesting the initial lack of counseling intensity
did not influence results. Another major limitation of the
PREDIMED is that the study was performed only in Spain,
in a population with a diet that is partly already reflective
of the MedDiet. There is therefore an urgent need to
explore EVOO and nut supplementation in a non-
Mediterranean population60. Recently, the National
Heart, Lung, and Blood Institute created a working group
in conjunction with the National Cancer Institute and
Office of Disease Prevention to address this interest in the
context of a MedDiet intervention in the American
population61, 62. Reflecting on the compelling evidence
presented above for the beneficial effects of a polyphenol-
rich Mediterranean diet, this is much needed for the
future of preventative CV care in America.
The accumulation of evidence in support of the Medi-
terranean diet for optimal health continues to grow63.
Overall, mortality and cardiometabolic mortality/events
were focused on in PREDIMED, but evidence also suggest
potential benefit in cognitive health64, 65, cancer66, and
even incidence of fractures67. It is now clear that in the
PREDIMED cohort the MedDiet supplemented with nuts
or EVOO reduces cardiac events. The evidence presented
above shows that polyphenols likely contribute to this
effect through lowering inflammatory biomarkers, blood
pressure and reduction of new-onset T2DM, and obesity.
Although polyphenols play an important role in affecting
CVD as described in this review, the high-unsaturated fat
content of the Mediterranean diet also plays a crucial role
in preventing CVD. In fact, a recent presidential advisory
from the American Heart Association68 recommended to
increase the consumption of UFA, and substituting
saturated fatty acids for UFA to prevent CVD, without
specific recommendation on the amount of calories
deriving from total fat or UFA.
To date, however, we do not have enough evidence to
determine whether the high polyphenol content or the
high UFA content is the major driver of CVD prevention,
perhaps a combination of the two may exert the greatest
benefits.
Conclusion
In conclusion, the high polyphenols content of the
MedDiet and the increase in the overall antioxidant
endogenous system seen in patients assigned to supple-
mentation of EVOO and nuts, may explain, at least in
part, the beneficial effects reported in the PREDIMED.
However, the studies presented herein have limitations,
and future study is needed to determine whether poly-
phenols or UFA play a major role in preventing CVD and
metabolic disease, and importantly, whether the over-
whelming beneficial effects of the MedDiet can be repli-
cated in a non-Mediterranean countries.
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